Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-25 @ 6:30 AM
Study NCT ID:
NCT03945604
Status:
COMPLETED
Last Update Posted:
2022-08-12
First Post:
2019-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-09
First Submit QC Date:
None
Study First Post Date:
2019-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-09
Last Update Post Date:
2022-08-12
Last Update Post Date Type:
ACTUAL